Literature DB >> 26710305

Fibroids: Genotype and Phenotype.

Zehra Ordulu1.   

Abstract

Fibroids represent a major public health care problem as the most prevalent pelvic tumors in women of reproductive age and as the leading cause of gynecologic surgeries in the United States. The recent advances in the genomic technologies including genome-wide association studies and high-throughput sequencing provide insight into their pathogenesis and molecular classification. Understanding the molecular basis of fibroids may facilitate development of effective targeted treatment options of this very common disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26710305      PMCID: PMC4733577          DOI: 10.1097/GRF.0000000000000177

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  21 in total

Review 1.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma.

Authors:  Avery A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  2005-04-01

2.  Inherited susceptibility to uterine leiomyomas and renal cell cancer.

Authors:  V Launonen; O Vierimaa; M Kiuru; J Isola; S Roth; E Pukkala; P Sistonen; R Herva; L A Aaltonen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 3.  Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis.

Authors:  R Garcia-Torres; D Cruz; L Orozco; L Heidet; M C Gubler
Journal:  Nephrologie       Date:  2000

4.  Cytogenetic abnormalities in uterine myomas are associated with myoma size.

Authors:  M S Rein; W L Powell; F C Walters; S Weremowicz; R M Cantor; R L Barbieri; C C Morton
Journal:  Mol Hum Reprod       Date:  1998-01       Impact factor: 4.025

5.  Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.

Authors:  B J Quade; A P Pinto; D R Howard; W A Peters; C P Crum
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

6.  Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15.

Authors:  Bradley J Quade; Stanislawa Weremowicz; David M Neskey; Roberta Vanni; Carll Ladd; Paola Dal Cin; Cynthia C Morton
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

Review 7.  Genetic basis of uterine leiomyoma: involvement of high mobility group protein genes.

Authors:  W J Van de Ven
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1998-12       Impact factor: 2.435

8.  Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF.

Authors:  Steven D P Moore; Steven R Herrick; Tan A Ince; Michael S Kleinman; Paola Dal Cin; Cynthia C Morton; Bradley J Quade
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

9.  DNA hypomethylation and imbalanced expression of DNA methyltransferases (DNMT1, 3A, and 3B) in human uterine leiomyoma.

Authors:  Shuanfang Li; Tung-chin Chiang; Gloria Richard-Davis; J Carl Barrett; John A Mclachlan
Journal:  Gynecol Oncol       Date:  2003-07       Impact factor: 5.482

10.  Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors.

Authors:  Rainer Lehtonen; Maija Kiuru; Sakari Vanharanta; Jari Sjöberg; Leena-Maija Aaltonen; Kristiina Aittomäki; Johanna Arola; Ralf Butzow; Charis Eng; Kirsti Husgafvel-Pursiainen; Jorma Isola; Heikki Järvinen; Pasi Koivisto; Jukka-Pekka Mecklin; Päivi Peltomäki; Reijo Salovaara; Veli-Matti Wasenius; Auli Karhu; Virpi Launonen; Nina N Nupponen; Lauri A Aaltonen
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

View more
  4 in total

1.  Leiomyoma with KAT6B-KANSL1 fusion: case report of a rapidly enlarging uterine mass in a postmenopausal woman.

Authors:  Alessandra J Ainsworth; Nooshin K Dashti; Taofic Mounajjed; Karen J Fritchie; Jaime Davila; Rohini Mopuri; Rory A Jackson; Kevin C Halling; Jamie N Bakkum-Gamez; J Kenneth Schoolmeester
Journal:  Diagn Pathol       Date:  2019-04-25       Impact factor: 2.644

2.  Molecular and clinicopathologic characterization of intravenous leiomyomatosis.

Authors:  Zehra Ordulu; Hongyan Chai; Gang Peng; Anna G McDonald; Michele De Nictolis; Eugenia Garcia-Fernandez; David Hardisson; Jaime Prat; Peining Li; Pei Hui; Esther Oliva; Natalia Buza
Journal:  Mod Pathol       Date:  2020-04-27       Impact factor: 7.842

3.  Benign Metastasizing Leiomyomatosis to the Skin and Lungs, Intravenous Leiomyomatosis, and Leiomyomatosis Peritonealis Disseminata: A Series of Five Cases.

Authors:  João Boavida Ferreira; Rafael Cabrera; Filipa Santos; Andreia Relva; Hugo Vasques; António Gomes; António Guimarães; António Moreira
Journal:  Oncologist       Date:  2022-02-03

4.  Familial Predisposition to Leiomyomata: Searching for Protective Genetic Factors.

Authors:  Maria V Kuznetsova; Nelly S Sogoyan; Andrew J Donnikov; Dmitry Y Trofimov; Leila V Adamyan; Natalia D Mishina; Jekaterina Shubina; Dmitry V Zelensky; Gennady T Sukhikh
Journal:  Biomedicines       Date:  2022-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.